Inventor · disambiguated record
Thomas W. Von Geldern
Also filed as: GELDERN THOMAS W VON · VON GELDERN THOMAS W · VON GELDERN Thomas
20 granted patents·5 pending applications·496 citations·filing 1992–2021
95Inventor score
Files withABBOTT LAB12ABBVIE INC4UNITY BIOTECHNOLOGY INC4ABBOTT LABORTORIES1AUTOBAHN THERAPEUTICS INC1
Top patents by PatentIndex Score
25 records- 0196US5767144AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Jun 16, 1998·90 cites·30 claims
- 0295US7365093B2Endothelin antagonistsABBOTT LAB·Filed 2005·Granted Apr 29, 2008·18 cites·1 claims
- 0394US5326776AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1993·Granted Jul 5, 1994·92 cites·26 claims
- 0493US6946481B1Endothelin antagonistsABBOTT LAB·Filed 2002·Granted Sep 20, 2005·37 cites·26 claims
- 0593US5250548AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1992·Granted Oct 5, 1993·57 cites·16 claims
- 0692US6162927AEndothelin antagonistsABBOTT LAB·Filed 1997·Granted Dec 19, 2000·46 cites·10 claims
- 0789US7208517B1Endothelin antagonistsABBOTT LABORTORIES·Filed 2000·Granted Apr 24, 2007·35 cites·8 claims
- 0888US8748412B2Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulatorsLIAO JIAYU·Filed 2011·Granted Jun 10, 2014·29 cites·54 claims
- 0986US6462194B1Endothelin antagonistsABBOTT LAB·Filed 2000·Granted Oct 8, 2002·14 cites·9 claims
- 1086US6380241B1Treatment of diseases using endothelin antagonistsABBOTT LAB·Filed 2000·Granted Apr 30, 2002·13 cites·6 claims
- 1183US5622971AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Apr 22, 1997·25 cites·22 claims
- 1276US6124341AEndothelin antagonistsABBOTT LAB·Filed 1998·Granted Sep 26, 2000·21 cites·36 claims
- 1376US5731434AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Mar 24, 1998·15 cites·8 claims
- 1472US10072040B2Tylosin A analogs and derivativesABBVIE INC·Filed 2015·Granted Sep 11, 2018·1 cites·33 claims
- 1572US9988368B1Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical useUNITY BIOTECHNOLOGY INC·Filed 2017·Granted Jun 5, 2018·1 cites·19 claims
- 1670US7834012B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2006·Granted Nov 16, 2010·1 cites·10 claims
- 1769US8377913B2Vitamin D receptor activators and methods of makingABBVIE INC·Filed 2008·Granted Feb 19, 2013·1 cites·5 claims
- 1856US10329279B2Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical useUNITY BIOTECHNOLOGY INC·Filed 2018·Granted Jun 25, 2019·0 cites·18 claims
- 1955US2019270726A1Products of chiral synthesis of cis-imidazoline compounds and their useUNITY BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 2047US2023348364A1Isotopic thyromimetic compoundsAUTOBAHN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2146US2006264433A1Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)BACKES BRADLEY J·Filed 2006·Application pending·0 cites
- 2244US2006276549A1Combination and use of drugsJACOBSON PEER B·Filed 2006·Application pending·0 cites
- 2340US10238677B2Treatment of filarial diseasesABBVIE INC·Filed 2016·Granted Mar 26, 2019·0 cites·28 claims
- 2438US2016200757A1Tylosin a analogs and derivativesABBVIE INC·Filed 2016·Application pending·0 cites
- 2537US11111259B2Acylsulfonamide derivatives for treating senescence-associated diseases and disordersUNITY BIOTECHNOLOGY INC·Filed 2016·Granted Sep 7, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Thomas W. Von Geldern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →